Category Archives: Uncategorized

Valproate Products Drug Safety Communicaton

Share

Valproate Products: Drug Safety Communicaton – Risk of Impaired Cognitive Development in Children Exposed In Utero (During Pregnancy) Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics AUDIENCE: OBGYN, … Continue reading

Share
Posted in FDA 2011, Uncategorized | Tagged , , , , , , , , , , , | Comments Off on Valproate Products Drug Safety Communicaton

MedWatch February 2011 Safety Labeling Changes posting includes 53 products

Share

The MedWatch February 2011 Safety Labeling Changes posting includes 53 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and MEDICATION GUIDE. The “Summary Page” provides a listing of drug … Continue reading

Share
Posted in FDA 2011, Uncategorized | Tagged , , , | Comments Off on MedWatch February 2011 Safety Labeling Changes posting includes 53 products

Davol XenMatrix Surgical Graft: Class I Recall – Elevated Endotoxin Levels

Share

Davol XenMatrix Surgical Graft: Class I Recall – Elevated Endotoxin Levels AUDIENCE: Risk Manager, Surgery ISSUE: FDA notified healthcare professionals that several lots of XenMatrix Surgical Graft have been found to have elevated endotoxin levels. Endotoxins (pyrogens) are substances found in … Continue reading

Share
Posted in FDA 2011, Uncategorized | Tagged , , , , | Comments Off on Davol XenMatrix Surgical Graft: Class I Recall – Elevated Endotoxin Levels